Advertisement

Annals of Nuclear Medicine

, Volume 11, Issue 1, pp 37–39 | Cite as

Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors

  • Hitoya Ohta
  • Tomoo Komibuchi
  • Toshihiro Nishio
  • Toshiyuki Kitai
  • Shunji Yamamoto
  • Minoru Ukikusa
  • Hiroji Awane
  • Kunikatsu Irie
  • Masayuki Shintaku
Case Report

Abstract

We presented two cases of phyllodes tumor of the breast examined by99mTc-sestamibi (MIBI) two-phase scintimammography. In the case with malignant phyllodes tumor,99mTc-MIBI accumulation was recognized on both early and delayed images. In the case with benign phyllodes tumor, however,99mTc-MIBI accumulation was recognized on only the early image.99mTc-MIBI delayed imaging may have the potential to distinguish between benign and malignant phyllodes tumors.

Key words

technetium-99m-sestamibi scintimammography phyllodes tumor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosen PP, Oberman HA. Cystosarcoma phyllodes.In Atlas of Tumor Pathology: Tumors of the Mammary Gland, Rosai J, Sobin LH (eds.), Washington DC, Armed Forces Institute of Pathology, pp. 107–114, 1993.Google Scholar
  2. 2.
    Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases.Cancer 41: 1974–1983, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Liberman L, Bonaccio E, Hamele-Bena D, Abramson AF, Cohen MA, Dershaw DD. Benign and malignant phyllodes tumors: mammographic and sonographic findings.Radiology 198: 121–124, 1996.PubMedGoogle Scholar
  4. 4.
    Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriére J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.J Nucl Med 36: 1758–1765, 1995.PubMedGoogle Scholar
  5. 5.
    Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.J Nucl Med 36: 1784–1789, 1995.PubMedGoogle Scholar
  6. 6.
    Umpleby HC, Moore I, Royle GT, Guyer PB, Taylor I. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes.Ann R Coll Surg Engl 71: 285–288, 1989.PubMedGoogle Scholar
  7. 7.
    Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts.J Nucl Med 31: 1646–1653, 1990.PubMedGoogle Scholar
  8. 8.
    Moretti JL, Caglar M, Boaziz C, Calliat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?Eur J Nucl Med 22: 177–180, 1995.PubMedCrossRefGoogle Scholar
  9. 9.
    Maffioli L, Steens J, Pauwels E, Bombardieri E. Application of99mTc-sestamibi in oncology.Tumori 82: 12–21, 1996.PubMedGoogle Scholar
  10. 10.
    Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistant P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.J Nucl Med 35: 510–515, 1994.PubMedGoogle Scholar
  11. 11.
    Komori T, Matsui R, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I.In vitro uptake and release of201T1 and99mTc-MIBI in HeLa cell.KAKU IGAKU (Jpn J Nucl Med) 32: 651–658, 1995.Google Scholar
  12. 12.
    Lu G, Shin WJ, Huang HY, Long MQ, Sun Q, Liu YH, et al.99mTc-MIBI mammoscintigraphy of breast masses: early and delayed imaging.Nucl Med Commun 16: 150–156, 1995.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Hitoya Ohta
    • 1
  • Tomoo Komibuchi
    • 1
  • Toshihiro Nishio
    • 2
  • Toshiyuki Kitai
    • 2
  • Shunji Yamamoto
    • 2
  • Minoru Ukikusa
    • 2
  • Hiroji Awane
    • 2
  • Kunikatsu Irie
    • 3
  • Masayuki Shintaku
    • 3
  1. 1.Department of LaboratoriesOsaka Red Cross HospitalOsakaJapan
  2. 2.Department of SurgeryOsaka Red Cross HospitalJapan
  3. 3.Department of PathologyOsaka Red Cross HospitalJapan

Personalised recommendations